Chronic antioxidant use and changes in endothelial dysfunction: A review of clinical investigations

Canadian Journal of Cardiology

Volumn 15, Issue 8, 1999, Pages 895-903

  Aminbakhsh, Amin ^a   Mancini, G B John ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

Antioxidants; Endothelium; Nitric oxide; Oxygen free radicals; Ultrasound

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CARVEDILOL; CELL ADHESION MOLECULE; COLESTYRAMINE; DILTIAZEM; MEVINOLIN; OMEGA 3 FATTY ACID; PERINDOPRIL; PLACEBO; PROBUCOL; SIMVASTATIN; TROGLITAZONE;

BLOOD VESSEL REACTIVITY; CELL FUNCTION; CELL INTERACTION; CLINICAL TRIAL; CORONARY ARTERY DISEASE; ENDOTHELIUM CELL; HUMAN; LONG TERM CARE; ORAL DRUG ADMINISTRATION; OUTCOMES RESEARCH; PROPHYLAXIS; RESISTANCE BLOOD VESSEL; REVIEW; VASCULAR ENDOTHELIUM; VASODILATATION;

ADMINISTRATION, ORAL; ANTIOXIDANTS; CORONARY DISEASE; ENDOTHELIUM, VASCULAR; HUMANS; REACTIVE OXYGEN SPECIES; TREATMENT OUTCOME;

EID: 0032781557     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Diaz MN, Frei B, Vita JA, Keaney JF. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997;337:408-16.
2. Chin JH, Azhar S, Hoffman BB. Inactivation of endothelium derived relaxing factor by oxidized lipoproteins. J Clin Invest 1992;89:10-8.
3. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low density lipoproteins. Nature 1990;344:160-2.
4. Kugiyama K, Ohgushi M, Sugiyama S, et al. Lysophosphatidylcholine inhibits surface receptor-mediated intracellular signals in endothelial cells by a pathway involving protein C activation. Circ Res 1992;71:1422-8.
5. Keaney JF Jr, Gaziano JM, Xu A, et al. Low-dose α-tocopherol improves and high-dose α-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J Clin Invest 1994;93:844-51.
6. Keaney JF Jr, Xu A, Cunningham D, Jackson T, Frei B, Vita JA. Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation. J Clin Invest 1995;95:2520-9.
7. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993;91:2546-51.
8. Keaney JF Jr, Vita JA. Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action. Prog Cardiovasc Dis 1995;38:129-54.
9. Andersson TLG, Matz J, Ferns GAA, Änggard EE. Vitamin E reverses cholesterol-induced endothelial dysfunction in the rabbit coronary circulation. Atherosclerosis 1994;111:39-45.
10. Steward-Lee AL, Forster LA, Nourooz-Zadeh J, Ferns GAA, Änggard EE. Vitamin E protects against impairment of endothelium-mediated relaxation in cholesterol-fed rabbits. Arterioscler Thromb 1994;14:494-9.
11. Simon BC, Haudenschild CC, Cohen RA. Preservation of endothelium-dependent relaxation in atherosclerotic rabbit aorta by probucol. J Caidiovasc Pharmacol 1993;21:893-901.
12. Drexler H. Endothelial dysfunction: clinical implications. Prog Cardiovasc Dis 1997;39:287-324.
13. Boegehold MA. Heterogeneity of endothelial function within the circulation. Curr Opin Nephrol Hypertens 1998;7:71-8.
14. Motoyama T, Kawano H, Kugiyama K, et al. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. J Am Coll Cardiol 1998;32:1672-9.
15. Neunteufl T, Kostner K, Katzenschlager R, Zehetgruber M, Maurer G, Weidinger F. Additional benefit of vitamin E supplementation to simvastatin therapy on vasoreactivity of the brachial artery of hypercholesterolemic men. J Am Coll Cardiol 1998;32:711-6.
16. Mietus-Snyder M, Malloy MJ. Endothelial dysfunction occurs in children with two genetic hyperlipidemias: improvement with antioxidant therapy. J Pediatr 1998;133:35-40.
17. Hornig B, Arakawa N, Kohler C, Drexler H. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation 1998;97:363-8.
18. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995;332:488-93.
19. Anderson TJ, Meredith IT, Charbonneau F, et al. Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans. Circulation 1996;93:1647-50.
20. Green D, O'Driscoll G, Rankin JM, Maiorana AJ, Taylor RR. Beneficial effect of vitamin E administration on nitric oxide function in subjects with hypercholesterolaemia. Clin Sci (Colch) 1998;95:361-7.
21. Chowienczyk PJ, Kneale BJ, Brett SE, Paganga G, Jenkins BS, Ritter M. Lack of effect of vitamin E on L-arginine-responsive endothelial dysfunction in patients with mild hypercholesterolaemia and coronary artery disease. Clin Sci (Colch) 1998;94:129-34.
22. Elliott TG, Barth JD, Mancini GBJ. Effects of vitamin E on endothelial function in men after myocardial infarction. Am J Cardiol 1995;76:1188-90.
23. Green D, O'Driscoll G, Blanksby B, Taylor R. Lack of effect of vitamin E administration on basal nitric oxide function in male smokers and non-smokers. Clin Sci (Colch) 1995;89:343-8.
24. Gilligan DM, Sack MN, Guetta V, et al. Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolemia. J Am Coll Cardiol 1994;24:1611-7.
25. McDowell IFW, Brennan GM, McEneny J, et al. The effect of probucol and vitamin E treatment on the oxidation of low-density lipoprotein and forearm vascular responses in humans. Eur J Clin Invest 1994;24:759-65.
26. Devaraj S, Li D, Jialal I. The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1β secretion, and monocyte adhesion to endothelium. J Clin Invest 1996;98:756-63.
27. Weber C, Erl W, Weber K, Weber PC. Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers. Circulation 1996;93:1488-92.
28. Seljeflot I, Arnesen H, Brude IR, Nenseter MS, Drevon CA, Hjermann I. Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers. Eur J Clin Invest 1998;28:629-35.
29. Giugliano D, Marfella R, Acampora R, Giunta R, Coppola L, D'Onofrio F. Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension. Diabetes Care 1998;21:631-6.
30. Davl G, Romano M, Mezzetti A, et al. Increased levels of soluble P-selectin in hypercholesterolemic patients. Circulation 1998;97:953-7.
31. Cominacini L, Garbin U, Fratta Pasini A, et al. Troglitazone reduces LDL oxidation and lowers plasma E-selectin concentration in NIDDM patients. Diabetes 1998;47:130-3.
32. Goodhart DM, Anderson TJ. Role of nitric oxide in coronary arterial vasomotion and the influence of coronary atherosclerosis and its risks. Am J Cardiol 1998;82:1034-9.
33. Feletou M, Vanhoutte PM. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol 1988;93:515-24.
34. + ATP channels and adenosine in the regulation of coronary blood flow during exercise with normal and restricted coronary blood flow. J Clin Invest 1996;97:996-1009.
35. + channels. Circ Res 1997;80:1-10.
36. Gräfe M, Auch-Schwelk W, Hertel H, et al. Human cardiac microvascular and macrovascular endothelial cells respond differently to oxidatively modified LDL. Atherosclerosis 1998;137:87-95.
37. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 1994;330:1029-35.
38. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145-9.
39. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study. Lancet 1996;347:781-6.
40. Walldius G, Carlson LA, Erikson U, et al. Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol Quantitative Regression Swedish Trail (PQRST): a status report. Am J Cardiol 1988;62:37B-43B.
41. Regnström J, Walldius G, Nilsson S, et al. The effect of probucol on low density lipoprotein oxidation and femoral atherosclerosis. Atherosclerosis 1996;125:217-29.
42. Tardif JC, Cote G, Lesperance J, et al. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group. N Engl J Med 1997;337:365-72.